DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.

Biotechnology

Health Care

Therapeutics

DJS Antibodies

DJS Antibodies' headquarters in Oxford, United Kingdom

Amanda Hall

Alina Janney

Joe Illingworth

Amy Sawtell

Lara Bavinton

Genevieve Labbe

James Hennegan

The Research and Development Team at DJS Antibodies is responsible for the discovery and optimization of innovative monoclonal antibodies targeting G protein-coupled receptors (GPCRs) to combat chronic inflammatory diseases. This team, comprised of senior scientists and research associates, conducts in-depth scientific research, develops therapeutic candidates, and facilitates preclinical testing, driving the advancement of first-in-class therapies from concept to reality.

Research and Development Team

This department focuses on conducting and analyzing research to support organizational goals and initiatives.

Research Division

This department manages the efficient operation of laboratory processes and resources.

Laboratory Operations

This department focuses on scientific research and innovation to develop new products and technologies.

DJS Antibodies

Org chart

Teams

Research and Development Team

Research Division

Laboratory Operations

Research and Development

Offices

DJS Antibodies

Org chart

Teams

Research and Development Team

Research Division

Laboratory Operations

Research and Development

Offices

Related companies